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Abstract
Background: The ubiquitin-based molecular switch dictating error free versus error prone repair has been conserved 
throughout eukaryotic evolution. A central component of this switch is the homotrimeric clamp PCNA, which is 
ubiquitinated in response to genotoxic stress allowing recovery of replication forks blocked at sites of DNA damage. 
The particulars of PCNA ubiquitination have been elucidated in yeast and to a further extent recently in human cells. 
However, gaps in the detailed mechanism and regulation of PCNA polyubiquitination still persist in human cells.
Findings: We expand upon several studies and show that PCNA is polyubiquitnated in normal skin fibroblasts, and that 
this ubiquitination is dependant on RAD18. Furthermore we define the types of DNA damage that induce 
ubiquitination on PCNA. Cisplatin, methylmethane sulphonate and benzo(a)pyrene-diol-epoxide induce the 
polyubiquitination of PCNA to the same extent as UV while polyubiquitination is not detected after X-ray treatment. 
Moreover, we show that ubiquitination of PCNA is not regulated by cell cycle checkpoint kinases ATM-Chk2 or ATR-
Chk1. Significantly, we report that PCNA polyubiquitination is negatively regulated by USP1.
Conclusions: Our results demonstrate the importance of PCNA polyubiquitination in human cells and define the key 
regulator of this ubiquitination.
Introduction
In recent studies PCNA ubiquitination has been identi-
fied as an important modification in human cells [1-4].
Similar to yeast, human PCNA is monoubiquitinated by
hRad6/hRad18 (governs error-prone repair) which
increases the affinity for translesion polymerase Polη and
enables a polymerase switch in response to DNA damage
[4]. Moreover hRad18 also interacts with Polη thereby
facilitating its localization to sites of DNA damage [5].
PCNA is also polyubiquitinated by the hMms2/hUbc13/
SHPRH or hMms2/hUbc13/HLTF complex, which gov-
ern error-free repair and disruption of this polyubiquit-
ination leads to genomic instability resulting in increased
mutagenesis and gross chromosomal rearrangements
[1,2,6,7]. We have previously used cancer cell lines to
demonstrate PCNA polyubiquitination. However, the use
of cancer cells may result in a distortion of the physiolog-
ical damage response. Therefore, it remains to be deter-
mined whether PCNA polyubiquitination is important in
normal human fibroblasts and if this potential modifica-
tion depends on RAD18.
Another central question is how human cells regulate
mono and polyubiquitination of PCNA and hence how
they induce or limit the deployment of DNA repair
machinery in the presence or absence of damage. One
possibility is that PCNA ubiquitination is regulated by
cell cycle checkpoint kinases ATR-Chk1 or ATM-Chk2
given their central role in damage surveillance [8-11]. An
alternative possibility is deubiquitinating enzymes
(DUBs). DUBs are cysteine proteases that cleave ubiq-
uitin from mono and polyubiquitinated substrates. In
2006 Huang et al., were the first to reveal that USP1 nega-
tively regulates monoubiquitination of PCNA in the
absence of DNA damage in order to control TLS [12].
In this study we examined the details of PCNA polyu-
biquitination in normal human fibroblasts and cancer cell
lines. Contrary to previous studies, we found that PCNA
is mono and polyubiquitinated in primary human skin
fibroblasts after UV irradiation and that this modification
is dependant on RAD18. In addition, we found that
PCNA is polyubiquitinated in response to a variety of
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occurs on K164. Since cell cycle checkpoint kinases are
predominantly activated after DNA damage we also
sought to determine whether PCNA ubiquitination is
regulated by global sensors such as ATR or ATM. Similar
to studies in Xenopus, S. pombe and human cells, we
report that mono or polyubiquitination of PCNA is not
regulated by the cell cycle checkpoint kinases in human
cells [13-15]. Significantly, we confirm that the candidate
DUB for negatively regulating PCNA polyubiquitination
is USP1.
Experimental Procedures
Cell Culture, treatments and transfections
The A549, HEK 293T and HeLa, HCT116, GM038 (skin
fibroblasts passage 15) cell lines were cultured in DMEM
(Gibco, Invitrogen, Carlsbad, California, United States)
supplemented with 10% FBS (Gibco, Invitrogen, Carls-
bad, California, United States) and 1× Pen/Strep (Gibco,
Invitrogen, Carlsbad, California, United States). UV irra-
diation (30 J/m2) was performed using a UVC germicidal
lamp at a fluence rate of 1 J/m2/s. Cisplatin (obtained
from the Ottawa Hospital Pharmacy, Ottawa, Ontario,
Canada) and mitomycin C (Sigma, St. Louis Missouri,
United States) were added to cells for 3 hours at a dose of
160 μM and 0.04 μg/ml, respectively, after which they
were washed with PBS and supplemented with fresh
media. Cisplatin and MMC treated cells were lysed 3
hours post treatment. MMS (Sigma, St. Louis Missouri,
United States) was added directly to cells up to 0.02% for
45 minutes followed by immediate lysis. Cells were irradi-
ated with either 4 or 10 Gray of ionizing radiation and
harvested 6 hours post irradiation. For caffeine treat-
ment, cells were incubated for 1 hour with either 2.5, 10
or 20 mM caffeine (Sigma, St. Louis Missouri, United
States) prior to UV irradiation (30 J/m2). GM038, 293T
and Hela cells were transfected with siGENOME
SMARTpool reagent specific for either human RAD18 or
USP1 (Dharmacon Research, Lafayette, Colorodo, United
States) using oligofectamine (Invitrogen, Carlsbad, Cali-
fornia, United States). The transfections were performed
72 hours prior to harvesting the cells to achieve optimal
long-term knockdown. 293T were also transiently trans-
fected with either a GFP-tagged WT PCNA or K164R
PCNA DNA plasmid using GeneJuice transfection
reagent (Novagen) as per company protocol.
Immunoblotting
The method and antibodies for immunoblotting have
been described elsewhere [1,16].
Immunoprecipitation
This method has been described elsewhere [1,16].
Results
UV irradiation induces PCNA polyubiquitination in normal 
fibroblasts
To date PCNA polyubiquitination has not been reported
in normal human fibroblasts [4,13]. However, in a previ-
ous study we were the first to demonstrate that K63-
linked polyubiquitination is important in human fibro-
blasts and that PCNA is both mono and polyubiquit-
inated in cancer cell lines by Rad18 and Ubc13 [1]. This
was further corroborated by Motegi et al. whose studies
showed that PCNA polyubiquitination was also depen-
dant on the human RAD5 homolog SHPRH [2]. However,
Kannouche et al. only observed monoubiquitination of
PCNA in transformed fibroblasts noting that PCNA
polyubiquitination was either not important in human
cells, occurred at low levels, or quickly turned over [4].
Therefore, we sought to resolve this issue by determining
whether PCNA polyubiquitination was physiologically
relevant to primary fibroblasts. We chose to investigate
primary skin fibroblast GM038 since these cell types are
one of the first to encounter environmental mutagens.
GM038 cells were irradiated with 30 J/m2 of UVC and 3
hours post-treatment a band representing monoubiquit-
inated PCNA as well as a second band corresponding to
di-ubiquitinated PCNA appeared (Figure 1A). To confirm
that these were indeed ubiquitinated forms of PCNA, we
immunoprecipitated PCNA followed by immunoblotting
with an anti-ubiquitin antibody. Bands corresponding to
di and tri-ubiquitinated PCNA were identified in GM038
after UV treatment (Figure 1B). Similar to previous
results the anti-ubiquitin antibody failed to reveal
monoubiquitinated PCNA [1,16]. This seems to be a
property of the antibody since it seems to have a lower
affinity for monoubiquitinated substrates.
PCNA polyubiquitination is dependant on RAD18 in 
primary fibroblasts
In our previous study we demonstrated that disruption of
RAD18 abrogates PCNA polyubiquitination in several
cancer cell lines after UV irradiation [1]. Therefore, we
sought to determine whether this was the case in human
fibroblasts. GM38 cells were targeted with siRNA against
RAD18. As expected, RAD18 knockdown resulted in a
substantial decrease in the mono and di-ubiquitinated
species (Figure 1C). Therefore, PCNA polyubiquitination
seems to be an important physiological response to UV
damage in healthy cells.
PCNA is polyubiquitinated in response to a variety DNA 
damaging agents
Thus far, work from our laboratory has shown that UV
damage induces PCNA polyubiquitination. We have now
examined the ubiquitination status of PCNA after treat-
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the chemotherapeutic drug cisplatin (CPT), environmen-
tal carcinogen benzo(a)pyrene-diol-epoxide (BPDE),
methylmethane sulfonate (MMS), mitomycin C (MMC)
and X-irradiation (X-ray). We were able to detect mono
and polyubiquitinated PCNA in 293T, and HeLa cells
after CPT, and MMS treatment to approximately the
same extent as that of mono and polyubiquitination after
UV irradiation (Figure 2A-B). We were also able to detect
a dose dependant increase in mono and polyubiquitina-
tion in HeLa and A549 after BPDE treatment (Figure 2C).
Moreover, this ubiquitination occurred in cells expressing
WT K164 PCNA but not in cells expressing a mutant
K164R PCNA, which indicates that this is the major site
on which PCNA is ubiquitinated in human cells [Addi-
tional file 1]. Finally we were unable to detect an increase
in mono or polyubiquitinated PCNA after treatment with
MMC and X-ray which may indicate that PCNA ubiquit-
ination is a specific response to certain types of DNA
damage or occurs with different kinetics based on the
type of DNA damage.
Figure 1 PCNA ubiquitination in normal skin fibroblasts. (A) 
GM038 cells were either left untreated or UV irradiated with 30 J/m2 
and lysed 3 h post-treatment followed by immunoblotting for PCNA. 
(B) GM038 cells were irradiated with 30 J/m2 UV and lysed in boiling 
SDS, diluted in lysis buffer and subjected to immunoprecipitation with 
a PCNA antibody and detected with an anti-ubiquitin antibody. (C) 
GM038 cells were transfected with 100 nM of either control siRNA or 
siRNA RAD18. 72 hours post-transfection cells were treated as in figure 
1A.
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Figure 2 PCNA is polyubiquitinated in response to a variety of 
replication stressors. (A) 293T cells were untreated or treated with 
the indicated dose of UV (30 J/m2), CPT (160 μM), MMS (0.02%), MMC 
(40 ng/ml) or ionizing radiation (4 Gy) according to materials and 
methods. Both longer and shorter exposures are shown. (B) HeLa cells 
were treated the same as in A. (C) A549 and HeLa cells were treated 
with 0, 0.5 or 1 μM BPDE for 1 h and lysed 5 hours post-treatment fol-
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cell cycle checkpoint kinases
ATM and ATR are cell cycle checkpoint kinases activated
in response to DNA damage [17,18]. To determine
whether ATR or ATM regulate PCNA ubiquitination we
analyzed the effect of inhibiting their kinase activity by
incubating A549 and HeLa cells with 10 or 20 mM caf-
feine prior to UV irradiation. We demonstrate that PCNA
is mono and polyubiquitinated to the same extent in the
presence or the absence of caffeine (Figure 3A and 3B). It
is interesting to note that after UV irradiation there is a
modest increase in mono and polyubiquitination in the
caffeine treated A549 cells (Figure 3A, short exposure)
while levels of PCNA mono and polyubiquitination are
similar in untreated or caffeine treated HeLa cells (Figure
3B). To confirm that our caffeine doses were inhibiting
ATR or ATM we analyzed the p53 phosphorylation status
at serine 15 after UV irradiation in the A549 cell lines,
which express wild type p53 [19]. It was observed that 10
or 20 mM caffeine abolished the phosphorylation of p53
while a strong phosphorylated ser15 p53 signal was pres-
ent in the non-caffeine treated but UV irradiated A549
cells (Figure 3C).
A recent study implicating USP1 in negatively regulat-
ing monoubiquitinated PCNA led us to evaluate whether
USP1 is also involved in regulating PCNA polyubiquit-
ination [12]. Using siRNAs targeting USP1 in human
cells, we observed a substantial increase in the levels of
both monoubiquitinated and polyubiquitinated PCNA in
GM038, HeLa, A549, 293T, and HCT116 cells (Figure
Figure 3 Inhibition of ATR or ATM does not abrogate PCNA ubiq-
uitination. (A) A549 and (B) HeLa cells were incubated with the indi-
cated doses of caffeine 1 h prior to UV irradiation. Six hours after 
irradiation cells were lysed followed by immunoblotting for PCNA. (C) 
A549 cells were treated as in A followed by immunoblotting for phos-
phorylated S15 on p53.
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Figure 4 Knockdown of USP1 leads to increase PCNA ubiquitina-
tion. (A-E) All indicated cell lines were transfected with 100 nM of ei-
ther control siRNA or siRNA USP1. 72 hours post-transfection cells were 
lysed and immunoblotted for PCNA.
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gests USP1 as a regulator of PCNA polyubiquitination.
Discussion
In a previous study we were the first to show that K63-
linked polyubiquitination is important in skin fibroblasts
but did not demonstrate the substrate involved in these
cells [1]. Here we expand upon that study and demon-
strate that PCNA is the substrate for K63-linked polyu-
biquitination and that PCNA polyubiquitination is a
normal physiological response to DNA damage in normal
diploid skin fibroblast and that this process is dependant
on RAD18. Moreover, we report that PCNA is polyubiq-
uitinated in response to a variety of genotoxic agents that
distort DNA including UV, CPT, MMS and BPDE. This
would suggest that PCNA polyubiquitination is a com-
mon mechanism used to protect cells against the muta-
genic effects of DNA damage.
Thus far our data have shown that PCNA polyubiquit-
ination is induced by several DNA damaging agents in a
variety of human cell lines. Interestingly, the same repli-
cation stressors used in this study also activate a global
checkpoint response which is governed by two serine/
threonine kinases ATM and ATR. Their activation facili-
tates the recruitment and phosphorylation of other pro-
teins, including Chk1 and p53, which consequently arrest
cells at G1 [20,21]. Our interest in this pathway in regu-
lating PCNA ubiquitination stems from studies which
demonstrated that ATM and ATR activation are neces-
sary for phosphorylation and subsequent ubiquitination
of FancD2 [18]. Since FancD2 colocalizes with PCNA
after DNA damage we postulated that ATR or ATM may
similarly regulate PCNA ubiquitination. Inhibition of
ATR or ATM with caffeine showed no disruption in
PCNA ubiquitination. In fact it showed a marginal
increase in both PCNA mono and polyubiquitination, at
least in A549 cells. These results were similar to those
recently reported by Chang et al., and Niimi et al [14,15].
However, this does not rule out that PCNA ubiquitina-
tion is regulated by cell cycle checkpoint kinases; rather,
it may point to alternative pathways that may compensate
for the inhibition of ATM and ATR. Recently, the p38
SAPK-MK2 pathway was demonstrated to be involved in
the response to DNA damage converging on similar sub-
strates activated by ATR and ATM [9]. Since caffeine has
been shown to upregulate p38 activity one could postu-
late that the p38 pathway is compensating for the loss of
ATR/ATM [22]. Future studies will be required to deter-
mine whether inhibition of ATR, ATM and the p38 path-
way in combination abrogates PCNA ubiquitination.
Recent studies point towards DUBs as another means
to regulate PCNA ubiquitination [6]. For example, USP1
has been implicated in the constitutive deubiquitination
of monoubiquitinated PCNA and USP1 functions inde-
pendently of the cell cycle checkpoint kinases similar to
PCNA polyubiquitination [12,15]. Here we show that
USP1 is also involved in deubiquitinating polyubiquit-
inated PCNA, the implications of which are unknown.
Functionally, Huang et al. showed that disruption of
USP1 lead to increased spontaneous and UV induced
mutagenesis [12]. They postulated that the increase in
mutagenesis could be due to the dysregulated function of
Polη or recruitment of other error-prone polymerases to
the damaged sites [12]. In light of our data showing an
increase in PCNA polyubiquitination after USP1 disrup-
tion, another explanation for the increased mutagenesis
could be the contribution of unscheduled, illegitimate
and dysregulated homologous recombination. During the
writing of this manuscript Motegi et al, also published
corroborating data demonstrating an increase in polyu-
biquitination of PCNA after abrogating USP1 expression
[6].
In conclusion, our data show that PCNA polyubiquit-
ination is an important response to DNA damage and
that it is constitutively regulated by USP1 and not by cell
cycle checkpoint kinases. A challenge for future investi-
gations will be to elucidate whether PCNA ubiquitination
is a compartmentalized response simply regulated by
USP1 alone or regulated by other signaling pathways.
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